Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens
Srey Viseth Horm Nathalie Deboosere Ramona A. Gutiérrez Michèle Vialette Philippe Buchy
Philippe BUCHY
BUCHY Philippe
ORCID: 0000-0003-1372-3008
Evidence of two distinct phylogenetic lineages of dog rabies virus circulating in Cambodia 10.1016/j.meegid.2015.12.011
Evidence of human infection by a new mammarenavirus endemic to Southeastern Asia 10.7554/eLife.13135
Zika virus in Asia 10.1016/j.ijid.2016.11.420
Clinical Experience with Influenza Virus Sialidase Inhibitors 10.1007/978-3-7643-8927-7_7
Heterogeneity of Rabies Vaccination Recommendations across Asia 10.3390/tropicalmed2030023
Vaccine impact: Benefits for human health 10.1016/j.vaccine.2016.10.025
Contaminated Soil and Transmission of Influenza Virus (H5N1) 10.3201/eid1809.120402
Plague in Majunga, Madagascar 10.1016/s0140-6736(95)92944-4
Eurasian Tree Sparrows, Risk for H5N1 Virus Spread and Human Contamination through Buddhist Ritual: An Experimental Approach 10.1371/journal.pone.0028609
Rabies Situation in Cambodia 10.1371/journal.pntd.0000511
A prospective, comparative study of severe neurological and uncomplicated hand, foot and mouth forms of paediatric enterovirus 71 infections 10.1016/j.ijid.2017.04.005
Natural co-infection of influenza A/H3N2 and A/H1N1pdm09 viruses resulting in a reassortant A/H3N2 virus 10.1016/j.jcv.2015.11.008
Laboratory diagnostics in dog-mediated rabies: an overview of performance and a proposed strategy for various settings 10.1016/j.ijid.2016.03.016
Acute lower respiratory infections in ≥5 year -old hospitalized patients in Cambodia, a low-income tropical country: clinical characteristics and pathogenic etiology 10.1186/1471-2334-13-97
Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens 10.1186/s12879-016-1551-x
Seroprevalence of anti-H5 antibody in rural Cambodia, 2007 10.1016/j.jcv.2010.02.021
Early diagnosis of dengue disease severity in a resource-limited Asian country 10.1186/s12879-016-1849-8
Low Circulation of Zika Virus, Cambodia, 2007–2016 10.3201/eid2302.161432
Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai 10.1016/j.jcv.2010.08.005
Proteinuria during dengue fever in children 10.1016/j.ijid.2016.12.022
Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai 10.1186/1753-6561-5-s1-p114
Seroepidemiology of Human Enterovirus 71 Infection among Children, Cambodia 10.3201/eid2201.151323
Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007) 10.1097/qai.0b013e3181a254c2
Laboratory diagnosis of dengue. 10.1079/9781845939649.0184
Spatial epidemiology and climatic predictors of paediatric dengue infections captured via sentinel site surveillance, Phnom Penh Cambodia 2011–2012 10.1186/1471-2458-14-658
Aetiology of acute meningoencephalitis in Cambodian children, 2010–2013 10.1038/emi.2017.15
Environmental contamination and risk factors for transmission of highly pathogenic avian influenza A(H5N1) to humans, Cambodia, 2006-2010 10.1186/s12879-016-1950-z
Intense circulation of A/H5N1 and other avian influenza viruses in Cambodian live-bird markets with serological evidence of sub-clinical human infections 10.1038/emi.2016.69
Intensive Circulation of Japanese Encephalitis Virus in Peri-urban Sentinel Pigs near Phnom Penh, Cambodia 10.1371/journal.pntd.0005149
Viral and bacterial etiologies of community-acquired acute lower respiratory infections among hospitalized Cambodian patients 10.1186/1753-6561-5-s1-o9
Seroprevalence and Transmission of Human Influenza A(H5N1) Virus before and after Virus Reassortment, Cambodia, 2006–2014 10.3201/eid2302.161232
Two clustered cases of confirmed influenza A(H5N1) virus infection, Cambodia, 2011 10.2807/1560-7917.es2014.19.25.20839
Influenza A/H5N1 virus infection in humans in Cambodia 10.1016/j.jcv.2007.04.010
Influenza virus circulation in Cambodia 10.1186/1753-6561-5-s1-p6
Simultaneous detection of respiratory viruses in children with acute respiratory infection using two different multiplex reverse transcription-PCR assays 10.1016/j.jviromet.2009.07.004
Kinetics of Neutralizing Antibodies in Patients Naturally Infected by H5N1 Virus 10.1371/journal.pone.0010864
Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome 10.1186/1743-422x-8-398
Epidemiology of Leptospira Transmitted by Rodents in Southeast Asia 10.1371/journal.pntd.0002902
Hemagglutinin pseudotyped lentiviral particles: Characterization of a new method for avian H5N1 influenza sero-diagnosis 10.1016/j.jcv.2007.02.005
Effects of mammarenavirus infection (Wēnzhōu virus) on the morphology of Rattus exulans 10.1016/j.meegid.2017.05.023
Genetic variability of human metapneumovirus amongst an all ages population in Cambodia between 2007 and 2009 10.1016/j.meegid.2011.01.016
Influenza activity in Cambodia during 2006-2008 10.1186/1471-2334-9-168
Environment: a potential source of animal and human infection with influenza A (H5N1) virus 10.1111/j.1750-2659.2012.00338.x
Diversity of Orientia tsutsugamushi clinical isolates in Cambodia reveals active selection and recombination process 10.1016/j.meegid.2010.08.015
Use of a multiplex PCR/RT-PCR approach to assess the viral causes of influenza-like illnesses in Cambodia during three consecutive dry seasons 10.1002/jmv.21891
Long-Lasting Immune Protection and Other Epidemiological Findings after Chikungunya Emergence in a Cambodian Rural Community, April 2012 10.1371/journal.pntd.0004281
Serologic evidence of human influenza virus infections in swine populations, Cambodia 10.1111/j.1750-2659.2012.00382.x
Heterosubtypic Antibody Response Elicited with Seasonal Influenza Vaccine Correlates Partial Protection against Highly Pathogenic H5N1 Virus 10.1371/journal.pone.0017821
Genetic diversity and lineage dynamic of dengue virus serotype 1 (DENV-1) in Cambodia 10.1016/j.meegid.2011.06.019
Reemergence of Chikungunya Virus in Cambodia 10.3201/eid1812.120471
Differential proteomic analysis of virus-enriched fractions obtained from plasma pools of patients with dengue fever or severe dengue 10.1186/s12879-015-1271-7
A Single Residue Substitution in the Receptor-Binding Domain of H5N1 Hemagglutinin Is Critical for Packaging into Pseudotyped Lentiviral Particles 10.1371/journal.pone.0043596
Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens 10.1016/j.jviromet.2011.06.002
Broad-coverage molecular epidemiology of Orientia tsutsugamushi in Thailand 10.1016/j.meegid.2011.06.008
Pulmonary melioidosis in Cambodia: A prospective study 10.1186/1471-2334-11-126
Clinical and Virological Factors Influencing the Performance of a NS1 Antigen-Capture Assay and Potential Use as a Marker of Dengue Disease Severity 10.1371/journal.pntd.0001244
Evidence of Japanese encephalitis virus infections in swine populations in 8 provinces of Cambodia: Implications for national Japanese encephalitis vaccination policy 10.1016/j.actatropica.2011.07.008
Acute lower respiratory infections on lung sequelae in Cambodia, a neglected disease in highly tuberculosis-endemic country 10.1016/j.rmed.2013.07.018
Le laboratoire d'analyses de biologie médicale référent en zone tropicale : exemple du réseau international des Instituts Pasteur 10.1016/s0338-9898(05)80194-5
Emergence of the Asian 1 Genotype of Dengue Virus Serotype 2 in Viet Nam: In Vivo Fitness Advantage and Lineage Replacement in South-East Asia 10.1371/journal.pntd.0000757
National dengue surveillance in Cambodia 1980–2008: epidemiological and virological trends and the impact of vector control 10.2471/blt.09.073908
Dynamic of H5N1 virus in Cambodia and emergence of a novel endemic sub-clade 10.1016/j.meegid.2012.05.013
PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection 10.1186/1743-422x-9-106
Molecular epidemiology of Orientia tsutsugamushi in Cambodia and Central Vietnam reveals a broad region-wide genetic diversity 10.1016/j.meegid.2011.01.004
Genetic diversity of human rhinoviruses in Cambodia during a three-year period reveals novel genetic types 10.1016/j.meegid.2015.07.030
1482Sentinel Surveillance of Respiratory Viral Pathogens in Border Areas of Western Cambodia 10.1093/ofid/ofu052.1028
Evaluation of diagnostic tests: dengue 10.1038/nrmicro2459
Complex dynamic of dengue virus serotypes 2 and 3 in Cambodia following series of climate disasters 10.1016/j.meegid.2012.05.012
Aperçu des vaccins Ebola en phase clinique et préclinique de développement 10.1007/s13149-016-0521-2
Clinical and Virological Study of Dengue Cases and the Members of Their Households: The Multinational DENFRAME Project 10.1371/journal.pntd.0001482
Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia 10.1038/emi.2016.101
Diversity of bat astroviruses in Lao PDR and Cambodia 10.1016/j.meegid.2016.11.013
Genetic diversity of coronaviruses in bats in Lao PDR and Cambodia 10.1016/j.meegid.2016.11.029
Design of multiplexed detection assays for identification of avian influenza a virus subtypes pathogenic to humans by SmartCycler real-time reverse transcription-PCR 10.1128/JCM.01090-08
Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011 10.1371/journal.pone.0110713
Estimating the Burden of Japanese Encephalitis Virus and Other Encephalitides in Countries of the Mekong Region 10.1371/journal.pntd.0002533
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase 10.1016/j.vaccine.2009.08.056
Highly pathogenic influenza a(h5n1) virus survival in complex artificial aquatic biotopes 10.1371/journal.pone.0034160
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study 10.1016/S1473-3099(12)70121-4
Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus 10.1128/AAC.01773-10
Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia [BMC Medicine, 14, (2016) (171)], 10.1186/s12916-016-0701-8 10.1186/s12916-016-0765-5
First introduction of pandemic influenza A/H1N1 and detection of respiratory viruses in pediatric patients in Central African Republic 10.1186/1743-422X-10-49
Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice 10.2217/imt.14.40
Hantavirus genetic diversity 10.1007/978-94-007-2114-2_9
A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 Viruses 10.1128/JVI.06930-11
Rodent-borne hantaviruses in Cambodia, Lao PDR, and Thailand. 10.1007/s10393-011-0725-7
Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globally 10.1016/j.ijid.2016.02.1007
Seasonal influenza vaccination in patients with COPD: A systematic literature review 10.1186/s12890-017-0420-8
Assessing the performance of remotelysensed flooding indicators and their potential contribution to early warning for leptospirosis in Cambodia 10.1371/journal.pone.0181044
Leptospira and rodents in Cambodia: Environmental determinants of infection 10.4269/ajtmh.2012.11-0349
Acute undifferentiated febrile illness in rural Cambodia: A 3-year prospective observational study 10.1371/journal.pone.0095868
Dengue in Thailand and Cambodia: An assessment of the degree of underrecognized disease burden based on reported cases 10.1371/journal.pntd.0000996
Dengue: A continuing global threat 10.1038/nrmicro2460
Hantavirus seropositivity in rodents in relation to habitat heterogeneity in human-shaped landscapes of Southeast Asia 10.1016/j.sste.2016.04.002
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses 10.1128/JVI.06665-11
Respiratory virus infections in hospitalized children and adults in Lao PDR 10.1111/irv.12135
Dengue viruses cluster antigenically but not as discrete serotypes 10.1126/science.aac5017
Contaminated soil and transmission of influenza virus (H5N1) org/10.3201/eid1809.120402
Emergence and transmission of arbovirus evolutionary intermediates with epidemic potential 10.1016/j.chom.2014.05.008
Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: Clinical characteristics and treatment 10.1186/1471-2334-12-3
Orientia tsutsugamushi, agent of scrub typhus, displays a single metapopulation with maintenance of ancestral haplotypes throughout continental South East Asia 10.1016/j.meegid.2015.01.005
Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia | Saisonnalité de la grippe et calendrier de vaccination dans les zones tropicales et subtropicales de l'Asie du Sud et de l'Asie du Sud-Est 10.2471/BLT.13.124412
Biochemical and kinetic analysis of the influenza virus RNA polymerase purified from insect cells 10.1016/j.bbrc.2009.11.100
Biased mutational pattern and quasispecies hypothesis in H5N1 virus 10.1016/j.meegid.2011.10.019
Divergent seasonal patterns of influenza types A and B across latitude gradient in Tropical Asia 10.1111/irv.12372
Influenza A(H5N1) virus surveillance at live poultry markets, Cambodia, 2011 10.3201/eid1902.121201
Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study 10.1016/S1473-3099(14)71072-2
Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006 10.3201/eid1408.070912
Epidemiological Analysis of Influenza A Infection in Cambodian Pigs and Recommendations for Surveillance Strategies 10.1111/tbed.12204
More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniques 10.1371/journal.pntd.0000765
Caring for patients with rabies in developing countries - the neglected importance of palliative care 10.1111/tmi.12670
Asymptomatic humans transmit dengue virus to mosquitoes 10.1073/pnas.1508114112
A(H5N1) virus evolution in South East Asia 10.3390/v1030335
Influenza antiviral resistance in the Asia-Pacific region during 2011 10.1016/j.antiviral.2012.12.016
Human bocavirus amongst an all-ages population hospitalised with acute lower respiratory infections in Cambodia 10.1111/j.1750-2659.2012.00369.x
Recent discoveries of new hantaviruses widen their range and question their origins 10.1196/annals.1428.064
Phenotypic and genotypic characterization of dengue virus isolates differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome 10.1007/s00705-011-1100-2
Acute viral lower respiratory tract infections in cambodian children: Clinical and epidemiologic characteristics 10.1097/INF.0b013e31826fd40d
Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water 10.1128/AEM.02484-10
An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia 10.1186/s12916-016-0701-8
A Model for a Chikungunya Outbreak in a Rural Cambodian Setting: Implications for Disease Control in Uninfected Areas 10.1371/journal.pntd.0003120
Global burden of respiratory infections due to seasonal influenza in young children: A systematic review and meta-analysis 10.1016/S0140-6736(11)61051-9
A specific and sensitive antigen capture assay for NS1 protein quantitation in Japanese encephalitis virus infection 10.1016/j.jviromet.2011.06.008
Rabies Vaccine and Rabies Immunoglobulin in Cambodia: Use and Obstacles to Use 10.1111/jtm.12228
Risk factors associated with subclinical human infection with avian influenza a (H5N1) virus-cambodia, 2006 10.1086/599208
Mortality in Cambodia: An 18-month prospective community-based surveillance of all-age deaths using verbal autopsies 10.1177/1010539513514433
Quantitative analysis of nucleic acid hybridization on magnetic particles and quantum dot-based probes 10.3390/s90705590
DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin 10.1093/infdis/jit414
Human sentinel surveillance of influenza and other respiratory viral pathogens in border areas of western Cambodia 10.1371/journal.pone.0152529
Under-recognition and reporting of dengue in Cambodia: A capture-recapture analysis of the National Dengue Surveillance System 10.1017/S0950268811001191
Dual Combined Real-Time Reverse Transcription Polymerase Chain Reaction Assay for the Diagnosis of Lyssavirus Infection 10.1371/journal.pntd.0004812
Evaluation of commercially available anti-dengue virus immunoglobulin M tests 10.3201/eid1503.080923
Field Evaluation and Impact on Clinical Management of a Rapid Diagnostic Kit That Detects Dengue NS1, IgM and IgG 10.1371/journal.pntd.0001993
Evidence for persistence of and antiviral resistance and reassortment events in seasonal influenza virus strains circulating in Cambodia 10.1128/JCM.01687-09
Estimating the burden of leptospirosis among febrile subjects aged below 20 years in Kampong Cham communities, Cambodia, 2007-2009 10.1371/journal.pone.0151555
Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens 10.1371/journal.pntd.0004100
Amino acids 473v and 598p of PB1 from an avian-origin influenza A virus contribute to polymerase activity, especially in mammalian cells 10.1099/vir.0.036434-0
Specific nucleic acid detection using photophysical properties of quantum dot probes 10.1021/ac902039n
The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection - Suramin inhibits EV71 infection in vitro and in vivo 10.1038/emi.2014.60
Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody 10.1371/journal.pntd.0003171
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir 10.1128/AAC.00645-06
A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype 10.1128/JCM.01131-11
Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina Peninsula, 2004-2007 10.3201/eid1510.090115
A reliable diagnosis of human rabies based on analysis of skin biopsy specimens 10.1086/592969
No association between human herpesvirus 6 reactivation and cryptococcosis in human immunodeficiency virus-infected patients 10.1099/jmm.0.000992-0
Identification of molecular markers associated with alteration of receptor-binding specificity in a novel genotype of highly pathogenic avian influenza A(H5N1) viruses detected in Cambodia in 2013 10.1128/JVI.01887-14
Co-circulation of dengue virus type 3 genotypes in Vientiane capital, Lao PDR 10.1371/journal.pone.0115569
Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue 10.1371/journal.pone.0011671
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa 10.1016/j.antiviral.2009.03.003
Dengue incidence in urban and rural cambodia: Results from population-based active fever surveillance, 2006-2008 10.1371/journal.pntd.0000903
Epidemiological and virological characteristics of influenza in the western pacific region of the world health organization, 2006-2010 10.1371/journal.pone.0037568
Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus 10.1371/journal.pone.0016563
Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR 10.1016/j.jviromet.2011.10.013
Quantum-dot-based quantitative identification of pathogens in complex mixture 10.1117/12.851050
Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region 10.1111/irv.12522
Contributions from the silent majority dominate dengue virus transmission 10.1371/journal.ppat.1006965
Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges 10.1016/j.ijid.2019.07.016
Impact of vaccines on antimicrobial resistance 10.1016/j.ijid.2019.10.005
Vaccinating pregnant women against influenza needs to be a priority for all countries: An expert commentary 10.1016/j.ijid.2019.12.019
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects 10.1080/14760584.2020.1853532
Rotavirus vaccines performance: dynamic interdependence of host, pathogen and environment 10.1080/14760584.2021.1951247
Nathalie deboosere
deboosere Nathalie
ORCID: 0000-0002-2873-5485
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. 10.1016/j.celrep.2017.08.101
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227
Phenotypic assays for Mycobacterium tuberculosis infection. 10.1002/cyto.a.23129
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. 10.1021/acschembio.7b00091
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. 10.1038/srep29297
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis. 10.1111/cmi.12619
A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. 10.3791/51114
Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/
Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR. 10.1016/j.jviromet.2011.10.013
Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce. 10.1016/j.ijfoodmicro.2011.08.011
Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens. 10.1016/j.jviromet.2011.06.002
Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water. 10.1128/aem.02484-10
A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries. 10.1016/
Assessment of the removal and inactivation of influenza viruses H5N1 and H1N1 by drinking water treatment. 10.1016/j.watres.2010.01.013
Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. 10.1016/j.ijfoodmicro.2005.11.007
Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. 10.1016/j.ijfoodmicro.2003.10.015
Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. 10.1073/pnas.1707840114
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis. 10.1038/s41598-017-11843-4
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages. 10.1016/j.chom.2017.07.020
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. 10.1038/s41598-017-05453-3
Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. 10.1016/j.ijpharm.2017.05.030
Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. 10.3389/fcimb.2017.00137
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections. 10.2217/nnm-2016-0364
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. 10.1126/science.aag1006
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. 10.1007/s00401-016-1652-z
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization. 10.1016/j.str.2016.07.009
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. 10.1007/s00705-016-2771-5
[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. 10.1039/c5ob02630j
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. 10.1128/jvi.01473-15
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. 10.1016/j.vaccine.2015.03.083
Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. 10.1371/journal.ppat.1004650
[High content screening in chemical biology: overview and main challenges]. 10.1051/medsci/20153102016
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays. 10.1007/978-1-4939-2450-9_24
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. 10.1021/cb5007163
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis. 10.1128/aac.03705-14
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040
Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. 10.1021/jm500422b
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence. 10.1371/journal.pone.0047573
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200825u
A novel specific edge effect correction method for RNA interference screenings. 10.1093/bioinformatics/btr648
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. 10.1371/journal.pone.0026675
High-content screening in infectious diseases. 10.1016/j.cbpa.2011.05.023
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200076a
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. 10.4155/fmc.10.223
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. 10.1099/mic.0.038133-0
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645
Systematic genetic nomenclature for type VII secretion systems. 10.1371/journal.ppat.1000507
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. 10.1016/j.biomaterials.2009.09.044
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583
Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. 10.1177/1087057108328762
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. 10.1371/journal.ppat.0040033
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. 10.1128/jb.00469-07
[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062
Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. 10.1016/j.bmc.2006.12.009
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. 10.1128/iai.02086-05
Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. 10.1016/j.bmc.2006.03.033
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. 10.1128/iai.74.4.2128-2137.2006
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006
Tuberculosis: from genome to vaccine. 10.1586/14760584.4.4.541
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. 10.1074/jbc.m503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 10.1099/mic.0.27799-0
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. 10.1016/
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. 10.1086/421468
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. 10.1128/iai.72.4.2170-2176.2004
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. 10.1099/mic.0.26662-0
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. 10.1038/nm859
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. 10.1046/j.1365-2958.2002.03237.x
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. 10.1021/bi015732y
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology 10.1101/2021.06.30.450483